AVONDALE, PA — CQ Medical, the newly formed entity from the merger of CIVCO Radiotherapy and Qfix in October 2022, is set to unveil its enhanced product offerings at the 66th ASTRO Annual Meeting in Washington, D.C., from September 29 to October 1. This marks a significant evolution for the company, reflecting its commitment to integrating intelligence and empathy in its healthcare solutions, encapsulated in its Care Quotient philosophy: IQ + EQ = CQ.
Attendees at booth #927 will witness how CQ Medical combines cutting-edge medical technology with patient-centric approaches to enhance treatment outcomes. Key innovations include the SBRT Immobilization Solutions, featuring the Body Pro-Lok ONEBridge™ for improved patient positioning and the Symphony® Imaging, Treatment & Transfer Solutions designed for seamless patient transfers across modalities.
Additional highlights include BrachyGel™, a pioneering vaginal hydrogel for brachytherapy, and the non-invasive Encompass™ and Solstice™ SRS Immobilization Systems. The company also introduces BioXmark®, a liquid fiducial marker aiding in precise treatment delivery, and the kVue™ Pronumbra™ Head & Neck Immobilization System, setting new standards in proton therapy.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.